Trial Profile
A retrospective trial evaluated efficacy and safety of linezolid in paediatric patients with childhood tuberculous meningitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Tubercular meningitis
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record
- 17 Feb 2016 Results published in the Pediatric Infectious Disease Journal.